NCT03961321View on ClinicalTrials.gov

Stereotactic MR-guided Adaptive Radiation Therapy for Localized Prostate Cancer

CompletedOBSERVATIONAL

Enrollment

104

Participants

Timeline

Start Date

August 25, 2016

Primary Completion Date

April 17, 2019

Study Completion Date

April 17, 2019

Conditions

Prostatic Neoplasms

Interventions

RADIATION

stereotactic mr guided adaptive radiotherapy

Study patients will be treated with an online MR-guided hypofractionated course of radiotherapy in 5 fractions of 7.25 Gy per fraction delivered on the prostate with a simultaneous integrated sparing (SIS) of the urethra with a dose of 32.5 Gy in 5 fractions (6.5 Gy per fraction).

Trial Locations (1)

1081HV

VU University medical center, Amsterdam

All Listed Sponsors

lead

Amsterdam UMC, location VUmc

OTHER

NCT03961321 - Stereotactic MR-guided Adaptive Radiation Therapy for Localized Prostate Cancer | Biotech Hunter | Biotech Hunter